Reporting Date | Major Shareholder Name | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
05/15/2024 | NEA MANAGEMENT COMPANY, LLC | 4.79 M | $7.94 M | 0.00% | 14.15% |
05/15/2024 | TANG CAPITAL MANAGEMENT LLC | 3.00 M | $4.98 M | -10.00% | 8.86% |
05/10/2024 | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2.74 M | $4.54 M | 143.97% | 8.09% |
05/03/2024 | CARLYLE GROUP INC. | 2.70 M | $4.45 M | 0.00% | 7.98% |
05/08/2024 | RIVERVEST VENTURE MANAGEMENT LLC | 2.53 M | $4.21 M | 0.00% | 7.50% |
05/15/2024 | OCTAGON CAPITAL ADVISORS LP | 2.25 M | $3.74 M | 0.00% | 6.66% |
04/24/2024 | BML CAPITAL MANAGEMENT, LLC | 2.18 M | $3.62 M | 65.72% | 6.44% |
05/10/2024 | BLACKROCK INC. | 993,659 | $1.65 M | 1.05% | 2.94% |
05/10/2024 | VANGUARD GROUP INC | 970,796 | $1.61 M | -0.83% | 2.87% |
05/14/2024 | AISLING CAPITAL MANAGEMENT LP | 886,075 | $1.47 M | 0.00% | 2.62% |
05/15/2024 | ROCK SPRINGS CAPITAL MANAGEMENT LP | 751,730 | $1.25 M | 0.00% | 2.22% |
05/13/2024 | RENAISSANCE TECHNOLOGIES LLC | 593,295 | $985,000 | 48.18% | 1.75% |
05/10/2024 | ACUITAS INVESTMENTS, LLC | 404,048 | $670,720 | 100.00% | 1.20% |
05/14/2024 | ALDEBARAN CAPITAL, LLC | 396,410 | $658,041 | 100.00% | 1.17% |
05/13/2024 | GEODE CAPITAL MANAGEMENT, LLC | 332,703 | $552,363 | -2.01% | 0.98% |
05/14/2024 | VESTAL POINT CAPITAL, LP | 295,375 | $490,323 | -26.16% | 0.87% |
05/15/2024 | STATE STREET CORP | 247,430 | $410,734 | 0.00% | 0.73% |
05/15/2024 | MORGAN STANLEY | 227,159 | $377,085 | 81.84% | 0.67% |
05/13/2024 | BANK OF MONTREAL /CAN/ | 134,032 | $227,854 | 100.00% | 0.40% |
05/15/2024 | TWO SIGMA INVESTMENTS, LP | 130,589 | $216,778 | -28.43% | 0.39% |
05/07/2024 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 121,000 | $200,860 | 221.81% | 0.36% |
05/14/2024 | NORTHERN TRUST CORP | 112,143 | $186,157 | -3.86% | 0.33% |
05/03/2024 | GSA CAPITAL PARTNERS LLP | 88,020 | $146,000 | -7.22% | 0.26% |
05/14/2024 | JBF CAPITAL, INC. | 80,000 | $132,800 | 0.00% | 0.24% |
05/06/2024 | MARQUETTE ASSET MANAGEMENT, LLC | 73,770 | $122,459 | 100.00% | 0.22% |
05/15/2024 | CITADEL ADVISORS LLC | 66,145 | $109,801 | 584.16% | 0.20% |
05/15/2024 | GOLDMAN SACHS GROUP INC | 38,751 | $64,327 | -40.19% | 0.11% |
05/09/2024 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 37,503 | $62,255 | 0.00% | 0.11% |
04/25/2024 | BANK OF NEW YORK MELLON CORP | 34,227 | $56,815 | -22.21% | 0.10% |
05/02/2024 | FIFTH LANE CAPITAL, LP | 32,635 | $54,174 | -18.41% | 0.10% |
05/14/2024 | ALPS ADVISORS INC | 23,496 | $39,003 | 1.60% | 0.07% |
05/15/2024 | CSS LLC/IL | 20,288 | $33,678 | 0.00% | 0.06% |
04/29/2024 | COMMONWEALTH EQUITY SERVICES, LLC | 19,347 | $32,000 | 100.00% | 0.06% |
05/14/2024 | AMERICAN CENTURY COMPANIES INC | 18,226 | $30,255 | 0.00% | 0.05% |
05/13/2024 | NUVEEN ASSET MANAGEMENT, LLC | 18,041 | $29,948 | 0.00% | 0.05% |
05/15/2024 | PRELUDE CAPITAL MANAGEMENT, LLC | 17,223 | $28,590 | 100.00% | 0.05% |
05/15/2024 | TWO SIGMA ADVISERS, LP | 16,200 | $26,892 | 100.00% | 0.05% |
05/10/2024 | JPMORGAN CHASE & CO | 15,044 | $24,973 | -7.00% | 0.04% |
05/10/2024 | DIMENSIONAL FUND ADVISORS LP | 13,327 | $22,122 | 0.00% | 0.04% |
05/13/2024 | UBS GROUP AG | 11,875 | $19,713 | -27.81% | 0.04% |
05/09/2024 | RHUMBLINE ADVISERS | 10,972 | $18,206 | 3.61% | 0.03% |
05/07/2024 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 10,715 | $17,787 | -35.25% | 0.03% |
05/15/2024 | TOWER RESEARCH CAPITAL LLC (TRC) | 9,478 | $15,733 | 39.90% | 0.03% |
05/15/2024 | BARCLAYS PLC | 8,158 | $13,000 | -66.61% | 0.02% |
05/10/2024 | GROUP ONE TRADING, L.P. | 7,591 | $12,601 | 100.00% | 0.02% |
05/21/2024 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 6,388 | $10,604 | 65.66% | 0.02% |
05/13/2024 | AMERICAN INTERNATIONAL GROUP, INC. | 6,330 | $10,508 | -1.86% | 0.02% |
05/10/2024 | CITIGROUP INC | 6,036 | $10,020 | 115.80% | 0.02% |
05/10/2024 | WELLS FARGO & COMPANY/MN | 5,323 | $8,836 | 10.48% | 0.02% |
05/15/2024 | BANK OF AMERICA CORP /DE/ | 4,373 | $7,259 | -81.76% | 0.01% |
A. During the previous two years, 92 institutional investors and hedge funds held shares of Reneo Pharmaceuticals, Inc.. The most heavily invested institutionals were:
NEA Management Company, LLC: 4.79 M
TANG CAPITAL MANAGEMENT LLC: 3 M
HIGHBRIDGE CAPITAL MANAGEMENT LLC: 2.74 M
Carlyle Group Inc.: 2.7 M
RiverVest Venture Management LLC: 2.53 M
Octagon Capital Advisors LP: 2.25 M
A. 80.94% of Reneo Pharmaceuticals, Inc. stock is owned by institutional investors.
A. Institutional investors have bought a total of 31.28 M shares in the last 24 months. This purchase volume represents approximately $46.92 M in transactions.